Last updated 2026-08-08
- Raised $110M Series B led by Temasek, Jul 2022
Total raised
$110.0M
Last: B Round 2022-07
Stage
Series B
Founded
2021
Headcount
—
HQ
Shanghai, China
Sector
Health Tech & Life Sciences
About
RiboX Therapeutics is a global, clinical-stage biotechnology company dedicated to discovering and developing fully engineered circular RNA (circRNA) therapeutics. The company aims to overcome the limitations of mRNA therapeutics and realize the full potential of RNA medicines. Its pipeline spans various therapeutic areas, including radiation-induced xerostomia, monogenic rare diseases, autoimmune diseases, and metabolic diseases. RiboX has operations in China, the US, and Israel.
Funding history · 1 round · $110.0M total
2022-07
B Round
$110.0M
★ Temasek★ Eisai Innovation★ Lilly Asia Ventures★ Qiming Venture Partners★ Boehringer Ingelheim Venture Fund★ Vivo Equity Investment Management
Team · 13
Ling-Ling Chen
Founder · Co-founder
Weiyi Zhang
Founder · Co-founder, Chief Executive Officer
Jennifer Kang
Head of IP & Corporate Legal
Patrick Au
Head of Preclinical Development and Translational Medicine
Michelle Sun
Head of Clinical Development
Siqi Li
Head of Technology Platform
Mengyao Zheng
Head of CMC
Emma Pan
Head of Research
Roi Mashiach
Head of Site (Israel)
Mengtao Xiao
Head of Business Development
Mike Miao
Head of Business Operations
Yizhen Xu
Chief Medical Officer
Sectors & technology
Primary sector
Health Tech & Life Sciences
Technologies
Tags
biotechnologydrug-deliveryin-vivonanotechnologyrna-therapeutics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | riboxtx.com |
|---|
Identifiers & details
| Founded | 2021 |
|---|
Radar intelligence
Patents
| EPO | 8 |
|---|
Web history (Wayback)
| Domain | riboxtx.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|